Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2017 | 12-2006 | 12-1994 | 12-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,080 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 34,506 | 17,819 |
| TOTAL | $8,103 | $N/A | $N/A | $34,506 | $17,819 |
| Non-Current Assets | |||||
| PPE Net | 1,103 | N/A | N/A | N/A | N/A |
| Investments And Advances | 0 | 0 | 0 | 68,214 | 0 |
| Other Non-Current Assets | 945 | 0 | 0 | 2,947 | 41,066 |
| TOTAL | $2,048 | $N/A | $N/A | $71,161 | $41,066 |
| Total Assets | $10,151 | $N/A | $N/A | $105,667 | $58,885 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 92 | 686 |
| Accounts payable and accrued liabilities | 1,077 | 0 | 0 | 4,230 | 3,286 |
| Accrued Expenses | 1,997 | N/A | N/A | 6,001 | 4,272 |
| TOTAL | $3,689 | $N/A | $N/A | $10,323 | $8,244 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 22,107 | 0 | 0 | 2,933 | 1,674 |
| TOTAL | $22,107 | $N/A | $N/A | $48,229 | $25,445 |
| Total Liabilities | $25,796 | $N/A | $N/A | $58,552 | $33,689 |
| Shareholders' Equity | |||||
| Common Shares | 1 | N/A | N/A | 357 | 350 |
| Retained earnings | -15,743 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 0 | 0 | 0 | -1,976 | 0 |
| TOTAL | $-15,645 | $N/A | $N/A | $91,110 | $88,078 |
| Total Liabilities And Equity | $10,151 | $0 | $0 | $149,662 | $121,767 |